These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 20108381)

  • 1. Prolonged vastus lateralis denervation after botulinum toxin type A injection.
    Dunne JW; Singer BJ; Silbert PL; Singer KP
    Mov Disord; 2010 Feb; 25(3):397-401. PubMed ID: 20108381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An open label pilot investigation of the efficacy of Botulinum toxin type A [Dysport] injection in the rehabilitation of chronic anterior knee pain.
    Singer BJ; Silbert PL; Dunne JW; Song S; Singer KP
    Disabil Rehabil; 2006 Jun; 28(11):707-13. PubMed ID: 16809213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Botulinum toxin type A for the treatment of sialorrhoea in amyotrophic lateral sclerosis: a clinical and neurophysiological study.
    Gilio F; Iacovelli E; Frasca V; Gabriele M; Giacomelli E; Picchiori F; Soldo P; Cipriani AM; Ruoppolo G; Inghilleri M
    Amyotroph Lateral Scler; 2010 Aug; 11(4):359-63. PubMed ID: 19929745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Botulinum toxin treatment of hip adductor spasticity in multiple sclerosis].
    Wissel J; Entner T
    Wien Klin Wochenschr; 2001; 113 Suppl 4():20-4. PubMed ID: 15506048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of refractory anterior knee pain using botulinum toxin type A (Dysport) injection to the distal vastus lateralis muscle: a randomised placebo controlled crossover trial.
    Singer BJ; Silbert PL; Song S; Dunne JW; Singer KP
    Br J Sports Med; 2011 Jun; 45(8):640-5. PubMed ID: 20418523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nerve stimulation boosts botulinum toxin action in spasticity.
    Frasson E; Priori A; Ruzzante B; Didonè G; Bertolasi L
    Mov Disord; 2005 May; 20(5):624-9. PubMed ID: 15726575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lower facial contouring with botulinum toxin type A.
    Tartaro G; Rauso R; Santagata M; Santillo V; Itro A
    J Craniofac Surg; 2008 Nov; 19(6):1613-7. PubMed ID: 19098563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanism of action of botulinum toxin type A in migraine prevention: a pilot study.
    Smuts JA; Schultz D; Barnard A
    Headache; 2004 Sep; 44(8):801-5. PubMed ID: 15330827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single CT-guided chemodenervation of the anterior scalene muscle with botulinum toxin for neurogenic thoracic outlet syndrome.
    Christo PJ; Christo DK; Carinci AJ; Freischlag JA
    Pain Med; 2010 Apr; 11(4):504-11. PubMed ID: 20202146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Botulinum toxin type a for the prophylaxis of chronic daily headache: subgroup analysis of patients not receiving other prophylactic medications: a randomized double-blind, placebo-controlled study.
    Dodick DW; Mauskop A; Elkind AH; DeGryse R; Brin MF; Silberstein SD;
    Headache; 2005 Apr; 45(4):315-24. PubMed ID: 15836567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dynamic polyelectromyography, neurolysis, and chemodenervation with botulinum toxin A for assessment and treatment of gait dysfunction.
    Esquenazi A; Mayer NH; Keenan MA
    Adv Neurol; 2001; 87():321-31. PubMed ID: 11347237
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparative impact of 2 botulinum toxin injection techniques for elbow flexor hypertonia.
    Mayer NH; Whyte J; Wannstedt G; Ellis CA
    Arch Phys Med Rehabil; 2008 May; 89(5):982-7. PubMed ID: 18452749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Botulinum toxin type A injections can be an effective treatment for pain in children with hip spasms and cerebral palsy.
    Lundy CT; Doherty GM; Fairhurst CB
    Dev Med Child Neurol; 2009 Sep; 51(9):705-10. PubMed ID: 19459910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Botulinum A in the treatment of equinus dynamic spasticity in children with cerebral palsy. Preliminary study].
    Mousny M; Allington N
    Rev Chir Orthop Reparatrice Appar Mot; 1999 May; 85(2):156-63. PubMed ID: 10392416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enduring efficacy of Botulinum toxin type A injection for refractory anterior knee pain.
    Silbert BI; Singer BJ; Silbert PL; Gibbons JT; Singer KP
    Disabil Rehabil; 2012; 34(1):62-8. PubMed ID: 21936736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of botulinum toxin in the treatment of drooling: a controlled clinical trial.
    Jongerius PH; van den Hoogen FJ; van Limbeek J; Gabreëls FJ; van Hulst K; Rotteveel JJ
    Pediatrics; 2004 Sep; 114(3):620-7. PubMed ID: 15342830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Botulinum toxin for the treatment of congenital entropion.
    Christiansen G; Mohney BG; Baratz KH; Bradley EA
    Am J Ophthalmol; 2004 Jul; 138(1):153-5. PubMed ID: 15234303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low back ache treatment with botulinum neurotoxin type A. Local experience in Kuwait.
    Nagarajan V; Al-Shubaili A; Ayad YM; Alexander J; Al-Ramezi K
    Med Princ Pract; 2007; 16(3):181-6. PubMed ID: 17409751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Botulinum toxin A injection under electromyographic guidance for treatment of spasmodic dysphonia.
    Casserly P; Timon C
    J Laryngol Otol; 2008 Jan; 122(1):52-6. PubMed ID: 17470307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determinants of responsiveness to botulinum toxin, casting, and bracing in the treatment of spastic equinus in children with cerebral palsy.
    Yap R; Majnemer A; Benaroch T; Cantin MA
    Dev Med Child Neurol; 2010 Feb; 52(2):186-93. PubMed ID: 20412253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.